Company: CI
Filing Date: 2025-10-30
Form Type: 10-Q
Source: 0001739940-25-000037
Chunk: 63

Company: Cigna Group
Filing Date: 2025-10-30
Form: 10-Q
Item: Part I, Item 1
Chunk 63
---
Short-term debt3,093 3,035 Liabilities of businesses held for sale— 2,410 Total current liabilities56,453 57,979 Non-current insurance and contractholder liabilities10,079 10,254 Deferred tax liabilities, net6,997 6,975 Other non-current liabilities3,873 3,215 Long-term debt30,947 28,937 Separate account liabilities7,556 7,278 TOTAL LIABILITIES115,905 114,638 Contingencies — Note 16Shareholders' equityCommon stock (1)4 4 Additional paid-in capital31,698 31,288 Accumulated other comprehensive loss(2,799)(2,341)Retained earnings47,028 43,519 Less: Treasury stock, at cost(34,126)(31,437)TOTAL SHAREHOLDERS' EQUITY41,805 41,033 Noncontrolling interests209 210 Total equity42,014 41,243 Total liabilities and equity$157,919 $155,881 

(1)Par value per share, $0.01; shares issued, 404 million as of September 30, 2025 and 403 million as of December 31, 2024; authorized shares, 600 million.

The accompanying Notes to the Consolidated Financial Statements (unaudited) are an integral part of these statements.

5

 The Cigna GroupConsolidated Statements of Changes in Total EquityUnauditedThree Months Ended September 30, 2025(In millions)CommonStockAdditionalPaid-inCapitalAccumulatedOtherComprehensive(Loss)RetainedEarningsTreasuryStockShareholders'EquityNoncontrollingInterestsTotalEquityRedeemableNoncontrollingInterestsBalance at June 30, 2025$4 $31,588 $(2,816)$45,564 $(34,126)$40,214 $216 $40,430 $— Effects of issuing stock for employee benefit plans110 (3)107 107 Other comprehensive income17 17 17 — Net income1,868 1,868 105 1,973 — Common dividends declared (per share: $1.51)(404)(404)(404)Repurchase of common stock— 3 3 3 Other transactions impacting noncontrolling interests